Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group.
Durand-Zaleski, I
Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group. [electronic resource] - American journal of perinatology Oct 1996 - 423-31 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0735-1631
10.1055/s-2007-994382 doi
Antigens, Human Platelet--immunology
Cost-Benefit Analysis
Costs and Cost Analysis
Epitopes--immunology
Female
Fetal Diseases--diagnosis
Humans
Infant, Newborn
Mass Screening--economics
Neonatal Screening--economics
Parity
Pregnancy
Prospective Studies
Thrombocytopenia--diagnosis
Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group. [electronic resource] - American journal of perinatology Oct 1996 - 423-31 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0735-1631
10.1055/s-2007-994382 doi
Antigens, Human Platelet--immunology
Cost-Benefit Analysis
Costs and Cost Analysis
Epitopes--immunology
Female
Fetal Diseases--diagnosis
Humans
Infant, Newborn
Mass Screening--economics
Neonatal Screening--economics
Parity
Pregnancy
Prospective Studies
Thrombocytopenia--diagnosis